Literature DB >> 16453149

Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice.

Caroline Oberholzer1, Sven K Tschoeke, Lyle L Moldawer, Andreas Oberholzer.   

Abstract

Caspase-9 is believed to play an essential role in sepsis-induced lymphocyte apoptosis. The aim of this study was therefore to evaluate its contribution within the caspase-dependent apoptosis pathway in a murine model of polymicrobial sepsis. Local injections of Z-LEHD-fmk, a specific caspase-9 inhibitor, into thymi of septic mice led to the complete inhibition of caspase-9, decreased apoptosis of resident tissue cells, and, in addition, reduced further downstream caspase-3 activity. In contrast to its systemic administration, only local injections improved the overall survival of septic mice. However, local injections of a pancaspase inhibitor (Z-VAD-fmk) did not improve survival, although caspase-3 activity was reduced to a similar degree as by the administration of Z-LEHD-fmk. These results indicate that local apoptosis of lymphatic tissue in polymicrobial sepsis is processed dependent of caspase-9 and suggests alternative caspase-dependent beneficial effects, which may determine a positive outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16453149     DOI: 10.1007/s00109-005-0017-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  39 in total

1.  Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis.

Authors:  K W Tinsley; S L Cheng; T G Buchman; K C Chang; J J Hui; P E Swanson; I E Karl; R S Hotchkiss
Journal:  Shock       Date:  2000-01       Impact factor: 3.454

2.  FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment.

Authors:  David N Zacks; Qiong-Duan Zheng; Ying Han; Rita Bakhru; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-12       Impact factor: 4.799

3.  Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury.

Authors:  Ahmet Colak; Alper Karaoğlan; Seref Barut; Sibel Köktürk; Ayşenur Iğdem Akyildiz; Mustafa Taşyürekli
Journal:  J Neurosurg Spine       Date:  2005-03

4.  LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.

Authors:  A Mignon; N Rouquet; M Fabre; S Martin; J C Pagès; J F Dhainaut; A Kahn; P Briand; V Joulin
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

5.  Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.

Authors:  S Gamen; A Anel; P Pérez-Galán; P Lasierra; D Johnson; A Piñeiro; J Naval
Journal:  Exp Cell Res       Date:  2000-07-10       Impact factor: 3.905

6.  Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation.

Authors:  M A Daemen; C van 't Veer; G Denecker; V H Heemskerk; T G Wolfs; M Clauss; P Vandenabeele; W A Buurman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 7.  Multiple cell death pathways as regulators of tumour initiation and progression.

Authors:  Marja Jäättelä
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

8.  Sepsis-induced apoptosis of the thymocytes in mice.

Authors:  S D Wang; K J Huang; Y S Lin; H Y Lei
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

9.  Lymphocyte subset responses to trauma and sepsis.

Authors:  W G Cheadle; R M Pemberton; D Robinson; D H Livingston; J L Rodriguez; H C Polk
Journal:  J Trauma       Date:  1993-12

10.  Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Authors:  E A Slee; M T Harte; R M Kluck; B B Wolf; C A Casiano; D D Newmeyer; H G Wang; J C Reed; D W Nicholson; E S Alnemri; D R Green; S J Martin
Journal:  J Cell Biol       Date:  1999-01-25       Impact factor: 10.539

View more
  10 in total

1.  Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.

Authors:  Amy C Fox; Elise R Breed; Zhe Liang; Andrew T Clark; Brendan R Zee-Cheng; Katherine C Chang; Jessica A Dominguez; Enjae Jung; W Michael Dunne; Eileen M Burd; Alton B Farris; David C Linehan; Craig M Coopersmith
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

2.  Suicidal erythrocyte death in sepsis.

Authors:  Daniela S Kempe; Ahmad Akel; Philipp A Lang; Tobias Hermle; Raja Biswas; Juliana Muresanu; Björn Friedrich; Peter Dreischer; Christiane Wolz; Ulrike Schumacher; Andreas Peschel; Friedrich Götz; Gerd Döring; Thomas Wieder; Erich Gulbins; Florian Lang
Journal:  J Mol Med (Berl)       Date:  2006-12-16       Impact factor: 4.599

3.  Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice.

Authors:  S K Tschoeke; C Oberholzer; D LaFace; B Hutchins; L L Moldawer; A Oberholzer
Journal:  Scand J Immunol       Date:  2008-10-08       Impact factor: 3.487

4.  AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.

Authors:  K Doi; X Hu; P S T Yuen; A Leelahavanichkul; H Yasuda; S M Kim; J Schnermann; T E N Jonassen; J Frøkiaer; S Nielsen; R A Star
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

5.  Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome.

Authors:  Kent Doi; Asada Leelahavanichkul; Xuzhen Hu; Karen L Sidransky; Hua Zhou; Yan Qin; Christoph Eisner; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

Review 6.  [Gene therapy for treatment of acute inflammatory immune response].

Authors:  S K Tschöke; A Oberholzer
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

7.  Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis.

Authors:  Marianna Miliaraki; Panagiotis Briassoulis; Stavroula Ilia; Aikaterini Polonifi; Marina Mantzourani; Efrossini Briassouli; Konstantinos Vardas; Serafim Nanas; Aikaterini Pistiki; Maria Theodorakopoulou; Theonymfi Tavladaki; Anna Maria Spanaki; Eumorfia Kondili; Helen Dimitriou; Sotirios Tsiodras; Dimitrios Georgopoulos; Apostolos Armaganidis; George Daikos; George Briassoulis
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 8.  A long way to go: caspase inhibitors in clinical use.

Authors:  Shanel Dhani; Yun Zhao; Boris Zhivotovsky
Journal:  Cell Death Dis       Date:  2021-10-15       Impact factor: 8.469

9.  Identification of immune-related endoplasmic reticulum stress genes in sepsis using bioinformatics and machine learning.

Authors:  Ting Gong; Yongbin Liu; Zhiyuan Tian; Min Zhang; Hejun Gao; Zhiyong Peng; Shuang Yin; Chi Wai Cheung; Youtan Liu
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

10.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.